Palamon Capital to sell OberScharrer to Nordic Capital

Palamon Capital Partners said March 13 that it agreed to sell OberScharrer Group to Nordic Capital. Financial terms weren’t disclosed. OberScharrer, an ophthalmology group in Germany, provides more than 85,000 treatments per year through its clinics. The sale will generate investment returns of 3.6x invested capital for Palamon.

DealsNorth AmericaUSBriefs